Alosetron used for the management of severe diarrhea-predominant irritable bowel syndrome in women only. It is sold under the brand name Lotronex. It is currently marketed by Prometheus Laboratories Inc. Reference standards of Alosetron API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Alosetron-d3 Hydrochloride
Catalogue No.:PA STI 004860
CAS :
Molecular Formula : C17H16D3ClN4O
Molecular Weight : 333.83
3,4-Didehydro Alosetron
Catalogue No.:PA 28 22590
Molecular Formula : C17H16N4O
Molecular Weight : 292.34
Alosetron
Catalogue No.:PA 01 3030000
Molecular Formula : C17H18N4O
Molecular Weight : 294.36
5-Methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one
Catalogue No.:PA 01 3031000
Molecular Formula : C12H12N2O
Molecular Weight : 200.24
6-Hydroxy Alosetron HCl
Catalogue No.:PA 01 3031001
Molecular Formula : C17H19ClN4O2
Molecular Weight : 346.82
4-(2-Phenylhydrazineyl)-5,6-dihydropyridin-2(1H)-one
Catalogue No.:PA 01 3031002
Molecular Formula : C11H13N3O
Molecular Weight : 203.25
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
